What is the half-life of DNSP-11?
DNSP-11 has a reported half life of Short (minutes), given subcutaneous (intra-cranial in animal models). That is why it is typically dosed daily in animal protocols. A shorter half life means more frequent dosing to keep blood levels steady, a longer one lets you space doses further apart.
Quick facts
- Half-life: Short (minutes)
- Route: Subcutaneous (intra-cranial in animal models)
- Typical schedule: Daily in animal protocols
- Cycle length: Pre-clinical
References
- Dopamine neuron stimulating actions of a GDNF propeptide — Bradley LH, Fuqua J, Richardson A, et al. (Gerhardt GA group). PLoS One, 2010
- Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques — Stenslik MJ, Evans A, Pomerleau F, et al. (Gerhardt GA, Bradley LH groups). Journal of Neuroscience Methods, 2018
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on DNSP-11
Last updated 2026-06-06.